Navigation Links
FDA approves first pocket-sized EKG machine

The government approved the first pocket-sized EKG machine, so small that it promises easier, faster heart measurements in ambulances, the emergency room - even a possible heart attack victim's bedroom. It's also the first hand-held computer-based medical device, part of a growing trend to miniaturize some of medicine's most important equipment.

Electrocardiograms, also called EKGs or ECGs, are recordings of the heart's electrical signals, used to diagnose heart attacks, irregular heartbeats and other cardiac problems.// The new PocketView ECG works just as well as full-size electrocardiograph machines, the Food and Drug Administration determined - but is the size of a handheld computer.

In fact, it's actually made from a Compaq hand-held personal digital assistant. Manufacturer MicroMedical Industries embedded that off-the-shelf PDA with miniaturized versions of the software and hardware that run full-size EKG machines. Twelve leads, the electrodes that stick to the chest and record electric currents during each heartbeat, plug into a wire that in turn plugs into the top of the device.

A doctor could view the readings right on the PDA screen. Or, if ambulance workers were recording the measurements, the PocketView ECG can transmit the results over wireless phones to a computer for a doctor to view. Or plug in a printer and the PocketView will spit out the electrocardiogram's traditional spike-covered paper printout.
'"/>




Page: 1

Related medicine news :

1. FDA approves new device to treat womens bleeding disorder
2. FDA approves surgical gel
3. FDA approves drug for rare liver disease
4. FDA approves Watson Pharmaceuticals Oxytrol patch
5. Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug
6. Madras High Court Disapproves of Comparative Advertisements
7. FDA approves Phase 0 trial which tests experimental drugs on humans
8. FDA approves CLARINEX-D 12 HOUR for seasonal allergic rhinitis
9. Study disapproves a new Asthma inhaler
10. GMC Disapproves Internet Doctor
11. Infant receives first bloodless liver transplant
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... ... August 16, 2017 , ... Ten outstanding teachers in the Greater Houston area ... will win a visit by a Houston Texans player, two tickets to a Texans ... years old can visit texanschecking.com/stars to nominate their favorite teacher with an essay of ...
(Date:8/16/2017)... Georgia (PRWEB) , ... August 16, 2017 , ... ... in Atlanta, opened their doors. They celebrate 30 years in business this year, ... create an up-to-date, inviting, tranquil space to serve their patients. , It ...
(Date:8/16/2017)... ... August 16, 2017 , ... Maury Regional Health has announced ... draws. By broadly deploying AccuVein devices, Maury Regional Medical Center is making vein visualization ... out of a needle stick and more importantly, helps our staff members locate a ...
(Date:8/16/2017)... ... 2017 , ... A global leader in the treatment of clubfoot, CURE ... Indian states—bringing the country one step closer to eliminating clubfoot as a lifelong disability ... on track to enroll 10,000 children in the clubfoot treatment program in this year ...
(Date:8/16/2017)... ... ... Fusion Flix Inc., a Telly Award Winning, Non Profit Corporation has announced their ... a partnership with the Amazon Video Direct Streaming Distribution Platform. , Their content will ... in 2018. Proceeds will be going to further health research. , Fusion Flix ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... -- Axium Pharmaceuticals Inc., the creator of the drug Truveta for ... of an IPO. The United States ... of a prescription epilepsy drug being $450.00-$1200.00 for a one month supply. ... AXIUM PHARMACEUTICALS, INC ... staggering figure is the fact that Americans spent $42 billion on anxiety ...
(Date:8/14/2017)... Israel , Aug. 15, 2017  BrainStorm ... adult stem cell technologies for neurodegenerative diseases, announced financial ... "We are in ... 3 trial to investigate NurOwn ® in ALS," ... Officer of BrainStorm. "We have agreements with Mass. General ...
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
Breaking Medicine Technology: